Preparation and Characterization of scFv-Coupled Immunoaffinity Column for Purification of Fibrinolytic Enzyme from Bacillus subtilis Natto-89

2020 ◽  
Vol 9 (2) ◽  
pp. 104-110
Author(s):  
SunIl Choe ◽  
CholJin Kim ◽  
UnHui Yun ◽  
HyonGwang Li ◽  
CholHo Kim

Background: The focus of this study was to prepare and characterize the single-chain variable fragment antibody (scFv)-coupled immunoaffinity column for purification of subtilisin BRC. Methods: The scFv against subtilisin BRC was immobilized onto CNBr-activated Sepharose 4B. Adsorption isotherm for subtilisin BRC on scFv-BRC-coupled Sepharose 4B was obtained and calculated the maximum binding capacity. The extraction conditions, including eluting solution, the concentration of eluting solution and flow rate, were optimized. Under the optimized eluting conditions, the dynamic binding capacity of the immunoaffinity column was determined. Results: The scFv-BRC-coupled Sepharose 4B for immunoaffinity purification of subtilisin BRC was prepared. The coupling efficiency was about 78.4%, e.g. about 8 mg of scFv-BRC was covalently coupled to 1 g CNBr-activated Sepharose 4B. The maximum equilibrium binding capacity (qm) and dissociation constant (Kd) of the immunoaffinity column for subtilisin BRC were 3.01 mg/mL and 0.465 mg/mL, respectively. The immunoaffinity chromatography conditions were optimized and the subtilisin BRC was purified 3.29-fold with 55.6%. Conclusion: The subtilisin BRC was effectively purified with high purity using scFv-BRC-coupled Sepharose 4B and the dynamic binding capacity of the column was determined. These results suggested that scFv-BRC can be used as a ligand for affinity purification of subtilisin BRC.

2009 ◽  
Vol 25 (1) ◽  
pp. 277-285 ◽  
Author(s):  
Michael S. Shapiro ◽  
Steve J. Haswell ◽  
Gary J. Lye ◽  
Daniel G. Bracewell

1985 ◽  
Vol 231 (1) ◽  
pp. 105-113 ◽  
Author(s):  
S A Fuller ◽  
A Philips ◽  
M S Coleman

A total of 56 stable murine hybridoma monoclones that produce homogeneous antibodies against human or calf terminal deoxynucleotidyltransferase have been established. All of the antibodies exhibited specific binding to various Mr forms of terminal transferase and eight possessed neutralizing activity. Results are presented that permitted characterization of ten of these antibodies with respect to their immunoglobulin class, their recognition of calf or human terminal-transferase Mr species by immunoblotting techniques and their recognition of distinct antigenic sites. Terminal transferase was purified in a single step by using an immunoaffinity column constructed with a monoclonal antibody exhibiting a high binding affinity for the enzyme. Single monoclonal antibodies were also used to bind selectively to terminal-transferase antigen in tissue slices and individual cells.


2009 ◽  
Vol 1216 (20) ◽  
pp. 4366-4371 ◽  
Author(s):  
Ann Marie Hardin ◽  
Chithkala Harinarayan ◽  
Gunnar Malmquist ◽  
Andreas Axén ◽  
Robert van Reis

Sign in / Sign up

Export Citation Format

Share Document